Hidalgo Medina Manuel sold $279K of GH
Hidalgo Medina Manuel sold 1,700 shares of Guardant Health, Inc. (GH) at an average of $164.24 ($163.94–$164.61, $0.28M total) across 2 trades on 2026-08-05.
How this was made
The 30-second read
Why it matters
The newest information is the specific open-market sale size, price range, and post-transaction holdings, which can influence short-term sentiment but lacks fundamental context.
Market read
Traders may monitor insider selling as a sentiment input, but this disclosure alone does not provide a new operational or financial catalyst.
What to watch
The filing does not state the director’s rationale, tax considerations, or whether other planned sales occurred; without those, the signal-to-noise is low.
Background
The article is a SEC Form 4 insider transaction disclosure for Guardant Health, Inc., reported by a director.
Ticker impact
Guardant Health director Hidalgo Medina Manuel sold 1,700 shares in open-market trades for about $279.2K, per a new Form 4 filed today.
Near-term impact is likely limited, though it can add modest sell-side optics if the market is sensitive to insider behavior.
The disclosure is primary-source (Form 4) and time-stamped, but the article provides no accompanying company-specific negative news, guidance change, or material event.
Market effects
Minimal, as the event is an individual insider transaction without sector-wide regulatory or clinical implications.
None indicated; this is a US-listed company insider sale disclosure.
None indicated.
Counterpoint
Because the sale is not tied to a stated 10b5-1 plan, some traders may over-interpret it as a signal, even though director sales are often liquidity-driven.
Key entities
- issuerGuardant Health, Inc.
US-listed company (GH) whose director reported an open-market sale of shares via Form 4.
- insiderHidalgo Medina Manuel
Director who sold 1,700 shares across two trades at about $163.945 to $164.605 per share.
